Clinical Trials

Our Research

Novocure is focused on generating clinical data that supports the use of Tumor Treating Fields (TTFields) therapy to improve treatment outcomes and quality of life for patients with multiple solid cell tumor types. We post clinical trial protocol information for all of our studies on the National Institutes of Health (NIH) website at www.clinicaltrials.gov.

The following company-sponsored trials are currently open and recruiting:

EF-14

Indication: Newly diagnosed glioblastoma multiforme

Protocol number: NCT00916409

PANOVA

Indication: Pancreatic adenocarcinoma

Protocol number: NCT01971281

INNOVATE

Indication: Ovarian carcinoma

Protocol number: NCT02244502

EF-21

Indication: 1-5 brain metastasis from non-small cell lung cancer

Protocol number: NCT01755624

Additional investigator-sponsored trials are also ongoing. For the most up-to-date clinical trial information, including protocol details, please refer to www.clinicaltrials.gov.

This information is for medical and scientific/educational purposes only. TTFields are experimental for the treatment of patients with new diagnosed glioblastoma, brain metastases, advanced pancreatic adenocarcinoma and ovarian carcinoma and has not been approved by the US Food and Drug Administration for commercial use in these indications. Limited by Federal law to investigational use only.


Delivered by Investis (opens in a new window)